Compare TNON & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TNON | PPCB |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8M | 2.6M |
| IPO Year | 2021 | 2011 |
| Metric | TNON | PPCB |
|---|---|---|
| Price | $2.27 | $0.28 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $44.38 | N/A |
| AVG Volume (30 Days) | ★ 255.9K | 196.5K |
| Earning Date | 11-12-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 84.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,944,000.00 | N/A |
| Revenue This Year | $46.86 | N/A |
| Revenue Next Year | $63.99 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 20.35 | N/A |
| 52 Week Low | $2.40 | $0.06 |
| 52 Week High | $45.50 | $6.79 |
| Indicator | TNON | PPCB |
|---|---|---|
| Relative Strength Index (RSI) | 34.65 | 23.83 |
| Support Level | N/A | $0.24 |
| Resistance Level | $4.18 | $0.40 |
| Average True Range (ATR) | 0.22 | 0.04 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 1.94 | 0.04 |
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.